Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 13Unknown 4Enrolling by invitation 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Neoplasms 33Breast Neoplasms 25Colorectal Neoplasms 20Prostatic Neoplasms 18Uterine Cervical Neoplasms 13Anxiety Disorders 13Brain Neoplasms 7Urinary Bladder Neoplasms 6Lymphoma, Follicular 6Lung Neoplasms 6Colonic Neoplasms 6Pain 5Depression 5Carcinoma, Hepatocellular 5Uterine Cervical Dysplasia 4Ovarian Neoplasms 4Motor Activity 4Inflammation 4Head and Neck Neoplasms 4Epilepsy 4Dementia 4Carcinoma, Non-Small-Cell Lung 4Stomach Neoplasms 3Smoking 3Sarcoma 3Rectal Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pancreatic Neoplasms 3Neoplastic Syndromes, Hereditary 3Lymphoma 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Enrolling by invitation × Risk Reduction Behavior × Clear all
NCT06968884 2025-05-13

Application of a Comprehensive Protocol Aimed at Reducing the Risk of Complications After Surgery for Sarcoma. Interventions Before, During and After Surgery for Known and Presumed Risk Factors Compared to Standard of Care in a Total of 300 Patients.

Region Stockholm

Phase NA Enrolling by invitation
300 enrolled
Sarcoma

Sarcoma, Risk Reduction Behavior

Data powered by HemOnc (CC BY 4.0) Colophon âš¡